Abstract
Clinical pathways are used in quality and cost control with indicators of length of stay. Cases of typhoid fever at Harapan Bunda Hospital include the criteria for the first rank of High Volume in 2018 and Problem Prone in the cost of treatment. The purpose of the study is to analyze the cost of treatment based on the implementation of clinical pathways in antibiotic therapy. Observational research with comparative studies of the use of injection antibiotics based on clinical pathway implementation. Retrospective data collection with dependent outcome therapy variables (cost and length of stay) while the independent variable regimen of antibiotic use. The population of typhoid fever patients according to the criteria for the implementation of clinical pathway ICD code (A0.10) 571 patients. Samples using total sampling that fulfills the criteria of direct inclusion are made into samples divided by the antibiotic regimen of the payment system, the group with the least amount excluded. There were 4 observation groups: generic ceftriaxone (n = 52) branded ceftriaxone (n = 51), generic cefotaxime (n = 53) and branded cefotaxime (n = 57) totaling 213 patients. Satatistic test results of length of stay (p> 0.05) explained that they did not have a significant difference, the average value (5.1596). Medical expenses for generic cefotaxime (Rp 4,072,002,6792), generic cherryax (Rp 4,479,480,4808), branded cefotaxime (Rp 6,945,258,3333) and branded ceftriaxone (Rp 7,296,933,5686). Conclusions based on JKN (AMiB) antibiotic payment systems are cheaper than general and the cheapest cefotaxime cheapest generic antibiotics.
Highlights
Clinical pathways are used in quality and cost control with indicators
Cases of typhoid fever at Harapan Bunda Hospital include the criteria for the first rank of High Volume
The purpose of the study is to analyze the cost of treatment based on the implementation
Summary
Penelitian ini bersifat observasional dengan studi perbandingan (comparative study) antara alternatif pengunaan antibiotik injeksi berdasarkan penerapan jalur klinis (clinical pathway). Pengambilan data dalam penelitian ini secara retrospektif pada variabel dependent adalah outcome terapi (biaya dan lama rawat) sedangkan variabel independent regimen penggunaan antibiotik. Pada penelitian ini kriteria inklusi adalah pasien yang berumur ≥ 17 tahun; pasien menggunakan terapi obat antibiotik injeksi sesuai dengan clinical pathway; pasien tanpa perlakuan khusus dan pasien tanpa penyakit penyerta, kriteria eksklusi adalah pasien umur.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.